Jürgen Jäger

Jürgen, the Head of CMC has more than 20 years of experience in drug development, spanning from early lab work to large-scale production of drug substances and drug products in different indications up to submission for market approval. He studied and received this Ph.D. in Organic Chemistry at the University of Stuttgart, followed by a 2-year postdoctoral fellowship at Cornell University (US), before starting his professional career at Arpida in antibiotic Research. After some years as lab head in medicinal chemistry, he focused then on CMC (Chemistry, Manufacturing, Control) activities. Jürgen held similar positions at Auris Medical, and became Head of CMC at Hemex and later Polyneuron Pharmaceuticals before joining Bioversys. He worked with small molecules, peptides, and up to therapeutic polymers, involving a different kinds of formulations/administration routes. During his career, he has gained a very broad overview of regulatory and quality requirements, managed many contract manufacturers, and was strongly involved in the discussions with local health authorities, as well as EMA and US FDA.